Unlocking the Versatile Potential: Adipose-Derived Mesenchymal Stem Cells in Ocular Surface Reconstruction and Oculoplastics

Adipose-derived mesenchymal stem cells (MSCs) show significant promise in ocular surface reconstruction and oculoplastics due to their regenerative and immunomodulatory properties. They are abundant, cost-effective, and relatively safe, making them ideal for clinical applications. MSCs have demonstrated efficacy in reducing inflammation, promoting wound healing, and improving tissue integration in conditions like dry eye syndrome, corneal injuries, and limbal stem cell deficiency. However, further research is needed to standardize clinical procedures, ensure long-term safety, and address ethical and regulatory considerations before MSCs can become standard treatments in ocular medicine.